United Cannabis Corporation (OTCPK:CNAB) acquired a 95% stake in Prana Therapeutics, Inc. for $6.4 million on July 14, 2017. United Cannabis issued 5,761,500 shares of its common stock as consideration for the purchase. Prana Therapeutics had gross revenue of $5,593 for the twelve months ended December 31, 2016. United Cannabis Corporation (OTCPK:CNAB) completed the acquisition of a 95% stake in Prana Therapeutics, Inc. on July 14, 2017.